Blogs (2)

BM213 is a selective C5aR1 agonist. It’s a useful research tool to study C5aR1 function

BAY-11-7082 inhibits the proliferation and induces the apoptosis of U266 cells through inhibiting NF-κB pathway. BAY 11-7082 ameliorates experimental diabetic neuropathy by modulating neuroinflammation and improving antioxidant defence.